IP Library Granted Patent US 6,846,497
Granted Patent B2
US 6,846,497 · App. 10/354,714 · Granted Jan 25, 2005

Rapidly expanding starches with altered crystalline structure

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,846,497
App. No.
10/354,714
Granted
Jan 25, 2005
Kind
B2
Abstract

This invention relates to a starch based tablet disintegrant useful at low addition levels and providing equally effective properties in water and physiological fluids. The starches are characterized by their low solubility in cold water, high swelling power and labile birefringence in the dry state, which rapidly disappears upon addition of water. The preferred starches are inhibited then processed to remove a portion of the granular structure.

Claims (17)

1. A starch based tablet disintegrant comprising a starch characterized by having cold water solubles of less than 2%, a swelling ratio of at least 2 (hydrated volume/dry volume), a salt swelling ratio of greater than 0.8, birefringence which disappears on addition of water at 50° C. and has an average particle size no greater than the native starch from which it was prepared.

2. The disintegrant of claim 1 wherein the starch is chosen from the group consisting of corn, potato, tapioca, sago, wheat and rice.

3. The disintegrant of claim 2 wherein the starch is modified with propylene oxide or ethylene oxide.

4. The disintegrant of claim 2 , wherein the starch is inhibited.

5. The disintegrant of claim 4 , wherein the starch is inhibited with a reagent chosen from the group consisting of sodium trimetaphosphate, phosphorus oxychloride and epichlorohydrin.

6. The disintegrant of claim 4 , wherein the inhibition is obtained by a heat/moisture treatment.

7. The disintegrant of claim 4 , wherein the starch is modified with propylene oxide and inhibited with phosphorus oxychloride.

8. A tablet comprising a starch of claim 1 .

9. The tablet of claim 8 , wherein the starch is modified.

10. The tablet of claim 8 , wherein the starch is modified and inhibited.

11. The tablet of claim 10 , wherein the starch crystallinity has been altered by spray drying.

12. The tablet of claim 10 , wherein the starch concentration is at or below 1%.

13. A tablet comprising a disintegrant, wherein the disintegrant consists essentially of the starch of claim 1 .

14. A tablet comprising a disintegrant, wherein the disintegrant consists essentially of the starch of claim 7 .

15. A starch characterized by having hot water solubles of less than 2% at 85° C., a swelling ratio of at least 2 (hydrated volume/dry volume), a salt swelling ratio of greater than 0.8 and birefringence which disappears on addition of water at 50° C. and has an average particle size no greater than the native starch from which it was prepared.

16. A tablet comprising the starch of claim 15 .

17. An inhibited, chemically modified starch characterized by having cold water solubles of less than 2%, a swelling ratio of at least 2 (hydrated volume/dry volume), a salt swelling ratio of greater than 0.8, birefringence which disappears on addition of water at 50° C. and has an average particle size no greater than the native starch from which it was prepared.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2012
From: NATIONAL STARCH LLC; BRUNOB II B.V.
To: CORN PRODUCTS DEVELOPMENT, INC.
Reel/Frame 027645/0724 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2008
From: NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION
To: BRUNOB II B.V.
Reel/Frame 021096/0293 →